What's the Cost of Polycystic kidney disease Diagnosis and Treatment in Republic of Korea?
| Republic of Korea | Turkey | Austria | |
|---|---|---|---|
| Symptomatic treatment | ≈ $900 | from $220 | ≈ $1,500 |
Your Benefits and Guarantees with Bookimed
Transparent Prices & Flexible Installments
No hidden fees – just official clinic prices. Pay at the clinic for Polycystic kidney disease treatment and use a flexible installment plan if needed.
Verified Clinics & Doctors Only
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Polycystic kidney disease treatment and have the necessary licenses to serve international patients worldwide.
Free 24/7 Assistance
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Polycystic kidney disease treatment journey.

Your personal Bookimed medical coordinator
- Supports you at every stage
- Helps choose the right clinic and doctor
- Ensures quick and convenient access to information
Best Polycystic kidney disease Treatment Centers in Republic of Korea: 9 Verified Options and Prices
Ewha Womans University Medical Center
Paik Nam-sun






MizMedi Women`s hospital
RE:YOUTH (YONSEI BH Arterial Stemcell Clinic)
Byung-hee Lee



Get a Medical Assessment for Polycystic kidney disease in Republic of Korea: Consult with Experienced Doctors Now
View all Doctors
Paik Nam-sun
Dr. Paik Nam-sun is a surgical oncologist at Ewha Womans University Medical Center in Seoul. He is recognized as one of the world's top 100 gastric and breast cancer surgeons. He performed the first breast-conserving surgery in South Korea. Dr. Paik also invented a proprietary stomach cancer technique to reduce reflux disease risk.
- Director of the Cancer Center for Women at Ewha Womans University Medical Center.
- Former President of Konkuk University Hospital.
- Served as the Director of the Korea Cancer Center Hospital.
- Former President of the Korean Society of Cancer Prevention.

Lee, Han-Byoel
The doctor is an expert in oncoplastic surgery and breast cancer, with extensive experience from prestigious institutions. The doctor holds an M.D. degree from Seoul National University College of Medicine and an M.S. degree in Surgery from the same institution. Additionally, the doctor earned a B.S. in biological sciences from the Korea Advanced Institute of Science and Technology (KAIST) and a Ph.D. in Surgery from Seoul National University Graduate School.

Byung-hee Lee
Dr. Byung-hee Lee is a neurosurgeon at RE:YOUTH Clinic in South Korea. He is a founding member of the Korean Society of Interventional Neurology. He also helped found the Korean Stroke Society. Dr. Lee treats complex conditions like Parkinson's, Alzheimer's, and cerebral aneurysms.
- Published 24 SCI theses in domestic and international medical journals.
- Delivered over 50 lectures at medical conferences worldwide.
- Maintains active membership in the World Stroke Society and American Stroke Association.
- Works at RE:YOUTH, the only Korean clinic providing arterial stem cell therapy.
Share this content
Video Stories from Bookimed Patients
Anna Leonova
Expert Overview about Polycystic kidney disease Treatment in Republic of Korea
Is Tolvaptan available for PKD treatment in South Korea?
Tolvaptan is available in South Korea for treating Autosomal Dominant Polycystic Kidney Disease (ADPKD). The Ministry of Food and Drug Safety approved it in 2015. National Health Insurance has covered this medication since 2019 for specific adult patients with rapid disease progression.
- Patient eligibility: Available for adults aged 19 to 50 with CKD stages 1-3.
- Insurance coverage: National Health Insurance covers costs for patients showing rapid kidney decline.
- Monitoring protocols: Monthly liver enzyme tests are mandatory due to potential hepatic side effects.
- Specialized centers: Major institutions like Asan Medical Center manage high-volume complex kidney cases.
Bookimed Expert Insight: South Korea is a leader in medical digitalization. Centers like Seoul National University Bundang Hospital use the BESTcare system to track drug titration. This digital monitoring is vital for Tolvaptan. It ensures precise dosing and safety for patients with fluctuating renal function.
Patient Consensus: While international discussions often focus on high costs, patients in Korea benefit from national insurance coverage. Many emphasize the need for strict adherence to the monthly blood test schedule required by local regulations.
Which are the best hospitals in Seoul for PKD and kidney transplants?
Asan Medical Center, Seoul National University Hospital, and Severance Hospital are the premier facilities for polycystic kidney disease and transplants. These JCI-accredited institutions report transplant success rates up to 98%. They utilize advanced robotic systems and multidisciplinary teams for complex inherited conditions.
- Asan Medical Center: Ranked as Korea's top transplant center with a 90% success rate.
- Seoul National University: Pioneers single-port robotic donor surgery for faster recovery and smaller incisions.
- Severance Hospital: Maintains high safety standards for high-risk, blood-type incompatible transplants in seniors.
- Samsung Medical Center: Employs a specialized multidisciplinary approach for all inherited kidney disease stages.
Bookimed Expert Insight: Patient volume is a primary indicator of quality in Seoul. Asan Medical Center treats 11,800 outpatients daily and manages 45% of Korea's heart transplants. This high volume across all organ categories ensures surgeons maintain peak proficiency for complex multi-organ cases often seen in advanced polycystic kidney disease.
Patient Consensus: Patients emphasize the need to start the Korean Organ Transplantation Registry paperwork early. Those who chose Asan Medical Center specifically praised the experienced surgeons and dedicated support for international patients.
Are there non-surgical treatments or clinical trials for PKD in Korea?
South Korea offers sophisticated non-surgical management for polycystic kidney disease through Tolvaptan medication and clinical research. Major Seoul-based medical centers provide access to phase 4 pharmacological trials and innovative arterial stem cell therapies. Most protocols focus on slowing cyst growth and preserving organ function.
- Medication therapy: Tolvaptan is approved to slow kidney cyst growth and preserve long-term function.
- Stem cell research: Centers explore urine-derived and arterial stem cell therapies for urinary system regeneration.
- Genetic cohorts: Multicenter observational studies establish genetic profiles for individualized precision treatment protocols.
- Supportive care: Programs emphasize intensive blood pressure regulation, glucose control, and targeted diet management.
Bookimed Expert Insight: Korea is a leader in digitalized medicine which significantly improves safety during longitudinal PKD care. Seoul National University Bundang Hospital was the first digital hospital globally. Their BESTcare system uses AI to analyze EHRs and track progression. This digital focus helps doctors identify small changes in cyst volume faster than traditional manual reviews.
Patient Consensus: Patients note it's important that international clinics in Seoul provide personalized coordination. Many find that having experts handle translations and appointments makes specialized pharmacological therapy much easier to manage.















